GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biolife Sciences BLFE · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2020

Revenue

$411,695

FY2014FY2020

Net income

−$1.3m

FY2014FY2020

Free cash flow

−$885,269

FY2014FY2020

Shareholders' equity

−$689,583

FY2014FY2020

Income statement

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$411,695——————
Gross profit−$985,000——————
Operating income−$1.2m—−$42,280−$329,000−$12,500−$21,160−$10,700
Net income−$1.3m−$1,134−$52,715−$340,000−$19,175−$28,880−$10,700
Diluted earnings per share-0.02-0.00-0.00-0.08-0.05-0.00-0.00

Balance sheet

At each fiscal year end

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$72,718$17$1,320$12,337———
Cash and short-term investments$34,740$17$1,320$12,337———
Total liabilities$762,301$1,171$222,186$195,438$146,164$126,988—
Debt$189,588—$142,197$140,697$113,179$101,679—
Shareholders' equity−$689,583−$1,154−$220,866−$183,101−$146,164−$126,988—
Shares outstanding74m34m19m4m0m55m55m

Cash flow

Fiscal years

FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$884,308$17−$12,517−$18,631−$11,500——
Capital spending−$961——————
Free cash flow−$885,269$17−$12,517−$18,631−$11,500——

Latest quarters

By quarter end

Feb 2022Aug 2021May 2021Feb 2021Aug 2020May 2020Feb 2020Nov 2019
Revenue————$127,989———
Gross profit————$5,417———
Operating income−$123−$135,000−$126,000−$57,298−$35,628−$8,900−$6,150−$10,150
Net income−$132−$143,000−$138,000−$67,359−$28,068−$10,800−$8,550−$14,050
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$1,040$231,866$273,191$317,534————
Cash and short-term investments$16$29,580$40,292$75,876————
Debt$387$395,358$375,018$359,367————
Shareholders' equity−$110−$835,663−$807,730−$713,489————

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%1500%1394583%-95%72%1669%5849%1850%6322%121%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 75-to-1 reverse split · 23 Jul 2018
  • 100-to-1 reverse split · 25 Aug 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.